Newsfeeds - Spark Newswire

1 minute read

Earnings

Biomerica: Q3 Earnings Insights

Today, 8:50 AM

Biomerica (NASDAQ:BMRA) reported its Q3 earnings results on Thursday, April 14, 2022 at 08:31 AM. Here's what investors need to know about the announcement. Earnings Biomerica beat estimated earnings by 90.0%, reporting an EPS of $-0.01 versus an estimate of $-0.1.

BMRA

1 minute read

Biomerica Posts Encouraging Results From InFoods Study As Irritable Bowel Syndrome Treatment

By Vandana Singh

Today, 8:50 AM

Biomerica Inc (NASDAQ: BMRA) has

BMRA

1 minute read

Biomerica Announces Topline Results From The Endpoint Clinical Trial Of Its InFoods IBS Treatment For Patients With Irritable Bowel Syndrome; Co. Reported ‘Multiple endpoints demonstrated statistically significant improvements’

By Benzinga Newsdesk

Today, 8:50 AM

InFoods® IBS Diagnostic-Guided Therapy is the first therapy of its kind using science, diet and technology to identify patient specific foods, which when eliminated, help reduce the symptoms of IBS

BMRA

2 minute read

Earnings

Biomerica’s Return On Capital Employed Overview

By Benzinga Insights

Today, 8:50 AM

According to data from Benzinga Pro, during Q2, Biomerica's (NASDAQ:BMRA) reported sales totaled $4.65 million. Despite a 27.05% increase in earnings, the company posted a loss of $1.13 million.

BMRA

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 8:50 AM

Gainers Biomerica (NASDAQ:BMRA) stock increased by 10.2% to $4.95 during Wednesday's after-market session. The market value of their outstanding shares is at $61.9 million. As per the news, the Q2 earnings report came out today.

ABEO

1 minute read

Earnings

Biomerica: Q2 Earnings Insights

By Benzinga Insights

Today, 8:50 AM

Biomerica (NASDAQ:BMRA) reported its Q2 earnings results on Wednesday, January 12, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

BMRA

1 minute read

Biomerica Q2 EPS $(0.09) Up From $(0.13) YoY, Sales $4.65M Up From $1.37M YoY

By Benzinga Newsdesk

Today, 8:50 AM

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 30.77 percent increase over losses of $(0.13) per share from the same period last year. The company reported $4.65 million in sales this

BMRA

1 minute read

Biomerica Q2 EPS $(0.09) Up From $(0.13) YoY

By Benzinga Newsdesk

Today, 8:50 AM

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 30.77 percent increase over losses of $(0.13) per share from the same period last year.

BMRA

2 minute read

Biomerica Reports Received Notice Of Allowance From Canadian Patent Office For Patent Covering Irritable Bowel Syndrome Food Sensitivity Testing & Treatment

By Benzinga Newsdesk

Today, 8:50 AM

Studies show that 13-20% of Canadians suffer from IBS at any given time1. The lifetime risk for a Canadian to develop IBS is 30%1. IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc.

BMRA

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 8:50 AM

ADMP